• Successful online-relations: By phrasing topics in a catchy way, and by prominently placing figurative marks (i.e. key visuals, trademarks and slogans), we generated outstanding click rates from general practitioners and internists.
  
  
• We successfully made customers try chiropody products of Gehwol, and positively recommend them on a Social Media platform. We also succeeded in specifically approaching a younger, web-experienced target group and to increase their awareness of and motivation to use Gehwol-products.
  
  
• We established the "Dr. Best Innovation Forum" as a brand-oriented communications platform for launching new Oral Care products. We achieved an attendance rate of about 40 journalists per launch, and generated media coverage of 100 Mio per year in the consumer press and trade media.
  
  
• We achieved the sell-in of regional newspapers into a media partnership for patient seminars and phone-in-sessions of the initiative "Measure your pain!" We successfully put the topic of innovative opioids under Narcotics Law for the treatment of chronic pain on the agenda, as we generated a total of 238 publications coverage of 60 Mio (online and print) within the regions of action (since 2005).
  
  
• We also successfully put the issue of the prescription of innovative opioid-analgesics on the agenda of the trade and consumer press, and continually increased media coverage up to 85 Mio prints per year. Thus, the number of prescriptions grows stronger than the market as a whole.
  
  
• We effectively defended Goldgeist® forte's market position in the market of anti-head louse agents. Despite an aggressive, highly competitive market environment, caused by a number of new market entries, Goldgeist® forte is able to maintain its solid position as second only to the market leader (OTC and prescriptions).
  
  
• We developed a combination module for pharmaceuticals, so that, for example for pharmaceuticals that are metabolised by isoenzyme Cytochrom P450, a warning message is displayed (the liver is a bottleneck for pharmaceuticals). The module was implemented during the campaign "Pain 60plus" for Mundipharma (www.schmerz60plus.de).
  
  
• By founding the initiative "Women's heart", we raised awareness of target groups from the professional field as well as from the general public for the women-specific risk-profile and the symptoms of coronary heart disease. We generated a high product-specific demand by publications that reached coverage of 76 Mio within 12 months.
  
  
• For our client we achieved a recommendation of a higher fluoride level in tooth pastes for children (500 ppm as opposed to the former recommendation of 250 ppm) by the German Society for Odontology and Oral Medicine (DGMK).
  
  
• We managed the media relations and further education programmes related to the model project "Action against bowel cancer", initiated by the German Cancer Society. In doing so, we increased demand for colorectal early diagnosis by 54 per cent among men and 36 per cent among women.
  
  
• By implementing a comprehensive, continuous media strategy and creating strategic alliances with scientific experts, we increased market share and brand awareness of the brands elmex®, aronal® as well as meridol®. We achieved up to 170 Mio namings by coverage/audience rate per year.